Groningen
Netherlands
8
2021-05-06
7
2024-12-03
These are the the leading inventors for applications assigned to SULFATEQ B.V.:
SULFATEQ B.V. based in Groningen, NL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Medicaments for the treatment of vasoconstriction related diseases or disorders
#2 | 2020-07-02 β Patent 11,730,741 granted on 2023-08-226-chromanol derivatives for use as a medicament
#3 | 2018-10-04 β Patent 10,426,771 granted on 2019-10-016-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases
#4 | 2018-09-06 β Patent 10,322,124 granted on 2019-06-186-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases
#5 | 2018-06-21 β Patent 10,676,452 granted on 2020-06-09Compound for the prophylaxis or treatment of organ damage
#6 | 2017-06-01 β Patent 9,913,841 granted on 2018-03-136-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases
#7 | 2015-12-03 β Patent 10,123,529 granted on 2018-11-13Compounds for protection of cells
#8 | 2013-08-08Compounds for Prevention of Cell Injury
Also check out Sulfateq B.V.'s (Groningen, Netherlands) applicant profile with 9 patent applications submitted.
33880 β